Point72 Europe (London) LLP Procept Bio Robotics Corp Transaction History
Point72 Europe (London) LLP
- $1.06 Billion
- Q1 2024
A detailed history of Point72 Europe (London) LLP transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Point72 Europe (London) LLP holds 320,431 shares of PRCT stock, worth $21.3 Million. This represents 1.49% of its overall portfolio holdings.
Number of Shares
320,431
Previous 530,071
39.55%
Holding current value
$21.3 Million
Previous $22.2 Million
28.72%
% of portfolio
1.49%
Previous 2.82%
Shares
3 transactions
Others Institutions Holding PRCT
# of Institutions
173Shares Held
38.1MCall Options Held
386KPut Options Held
259K-
Cpmg Inc Dallas, TX5.33MShares$354 Million100.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.25MShares$282 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$219 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.94MShares$195 Million0.09% of portfolio
-
Alliancebernstein L.P. New York, NY1.99MShares$132 Million0.04% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.96B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...